Repeat associated neurodegeneration in CANVAS
CANVAS 中重复相关的神经变性
基本信息
- 批准号:10536010
- 负责人:
- 金额:$ 42.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AtaxiaAtrophicAutopsyBasal GangliaBiological AssayBrain regionCRISPR/Cas technologyCellsCerebellar AtaxiaCerebellar DiseasesCerebellar degenerationComplexDNA Transposable ElementsDefectDevelopmentDiffuseDiseaseDisease ProgressionDisease modelDrosophila genusElementsExhibitsFaceGenesGeneticGoalsHumanImpairmentInduced pluripotent stem cell derived neuronsInheritance PatternsInheritedIntronsLeadLengthModelingMolecularMorbidity - disease rateNerve DegenerationNeuronsNeuropathyPathogenesisPathogenicityPathologicPathway interactionsPatientsPentanucleotide RepeatsPeptidesPeripheralPluripotent Stem CellsPoly(A) TailPopulationProsencephalonProteinsPurkinje CellsRNAReporterSensorySyndromeSystemTechnologyTestingTherapeuticToxic effectTranslatingTranslationsTrigeminal SystemWorkbasecerebral atrophyeffective therapygain of functioninduced pluripotent stem cellloss of functionmortalityneuron lossneuronal survivalneurotoxicitynovelsensory neuropathysomatosensorytherapeutic targettooltranscriptome
项目摘要
Abstract:
Cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS) is a late-onset, slowly
progressive and recessively inherited ataxia characterized by vestibular, cerebellar, and somatosensory
impairments and cerebellar degeneration that results in significant morbidity and early mortality. CANVAS is
caused by a biallelic, non-reference, pentameric AAGGG repeat expansion within the second intron of replication
factor complex subunit 1 (RFC1) gene in both familial and sporadic CANVAS, as well as a significant fraction of
all late-onset degenerative ataxias and sensory neuronopathies. Controls possess an average of 11 AAAAG
repeats at this locus, which is replaced with between 400-2000 AAGGG repeats in CANVAS patients. The
mechanism(s) by which this repeat expansion causes neurodegeneration are unknown. While CANVAS exhibits
a recessive pattern of inheritance, studies to date suggest that RFC1 expression is not impacted by the repeat
expansions. The expansion has the potential to be pathogenic within two different strand-specific contexts. On
the sense strand, the (AAGGG)n repeat sits within the poly(A) tail of an AluSx3 transposable element, while the
antisense strand (CCCTT)n repeat sits within the large second intronic region of RFC1. The goal of this
proposal is to define the mechanisms by which these repeat elements contribute to neurodegeneration
in CANVAS. To accomplish this, we will use a combination of patient-derived iPSC models alongside studies
using repeat-expressing reporters to investigate the expanded repeat within both its endogenous context as well
as within easily manipulable assay systems that will allow us to define the potential of these repeat elements to
elicit toxicity directly. Taken together, these studies will provide critical information needed to define the proximal
mechanism(s) and pathways that underlie neuronal toxicity and neurodegeneration within CANVAS – a critical
first step required for development of disease relevant therapeutics.
抽象的:
小脑性共济失调伴神经病和前庭无反射综合征 (CANVAS) 是一种迟发性、缓慢的疾病
以前庭、小脑和体感为特征的进行性和隐性遗传性共济失调
损伤和小脑变性导致显着的发病率和早期死亡。画布是
由复制的第二个内含子内的双等位基因、非参考、五聚体 AAGGG 重复扩增引起
家族性和散发性 CANVAS 中的因子复合体亚基 1 (RFC1) 基因,以及很大一部分
所有迟发性退行性共济失调和感觉神经病。控件平均拥有 11 AAAAG
该基因座上的重复序列在 CANVAS 患者中被 400-2000 个 AAGGG 重复序列取代。这
这种重复扩张导致神经变性的机制尚不清楚。在CANVAS展出的同时
隐性遗传模式,迄今为止的研究表明 RFC1 表达不受重复序列的影响
扩展。这种扩展有可能在两种不同的特定链环境中致病。在
有义链中,(AAGGG)n 重复序列位于 AluSx3 转座元件的 Poly(A) 尾内,而
反义链 (CCCTT)n 重复序列位于 RFC1 的第二大内含子区域内。此举的目标
提案是定义这些重复元件导致神经退行性变的机制
在画布中。为了实现这一目标,我们将结合使用源自患者的 iPSC 模型和研究
使用重复表达记者来调查其内源性背景下的扩展重复
就像在易于操作的分析系统中一样,这将使我们能够定义这些重复元件的潜力
直接引起毒性。总而言之,这些研究将提供定义近端所需的关键信息。
CANVAS 内神经元毒性和神经变性的机制和途径——一个关键
开发疾病相关疗法所需的第一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter K Todd其他文献
Peter K Todd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter K Todd', 18)}}的其他基金
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
10553169 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
- 批准号:
10271293 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
10438531 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
- 批准号:
10451594 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
- 批准号:
10669050 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
9890664 - 财政年份:2020
- 资助金额:
$ 42.49万 - 项目类别:
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia
ALS 和额颞叶痴呆中的六核苷酸重复翻译
- 批准号:
9920791 - 财政年份:2016
- 资助金额:
$ 42.49万 - 项目类别:
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia
ALS 和额颞叶痴呆中的六核苷酸重复翻译
- 批准号:
10680134 - 财政年份:2016
- 资助金额:
$ 42.49万 - 项目类别:
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome
脆性 X 相关震颤/共济失调综合征中的 CGG 重复相关翻译
- 批准号:
8670071 - 财政年份:2014
- 资助金额:
$ 42.49万 - 项目类别:
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome
脆性 X 相关震颤/共济失调综合征中的 CGG 重复相关翻译
- 批准号:
9914611 - 财政年份:2014
- 资助金额:
$ 42.49万 - 项目类别:
相似海外基金
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 42.49万 - 项目类别:
In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI
利用定量梯度回忆回波 MRI 体内鉴定阿尔茨海默病前驱期的萎缩前脑神经变性
- 批准号:
10448152 - 财政年份:2022
- 资助金额:
$ 42.49万 - 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
- 批准号:
10007577 - 财政年份:2019
- 资助金额:
$ 42.49万 - 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
- 批准号:
10242918 - 财政年份:2019
- 资助金额:
$ 42.49万 - 项目类别:
Analysis of the role of AMPK in the retina for the development of a novel treatment for atrophic age-related macular degeneration
分析 AMPK 在视网膜中的作用,以开发治疗萎缩性年龄相关性黄斑变性的新方法
- 批准号:
18K09457 - 财政年份:2018
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regeneration of atrophic salivary glands by reconstructing tissue macrophages using amniotic fluid-derived cells
利用羊水来源的细胞重建组织巨噬细胞来再生萎缩的唾液腺
- 批准号:
19K21370 - 财政年份:2018
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The study to detect early-stage pancreatic cancer based on the data from molecular biology about the atrophic acinar cell surrounding carcinoma in situ.
该研究基于原位癌周围萎缩性腺泡细胞的分子生物学数据来检测早期胰腺癌。
- 批准号:
18K07897 - 财政年份:2018
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multiple control and visualization of self-somatic- stem cells for atrophic jaw bone augmentation
用于萎缩颌骨增量的自体干细胞的多重控制和可视化
- 批准号:
17H04394 - 财政年份:2017
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Delivery of concentrated peripheral blood derived EPCs and functional miRNAs for atrophic salivary gland regeneration
输送浓缩的外周血来源的 EPC 和功能性 miRNA 以促进萎缩唾液腺再生
- 批准号:
17K17272 - 财政年份:2017
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of novel oligonucleotide therapeutics using functional liposomes for atrophic muscular disorder
使用功能性脂质体开发治疗萎缩性肌肉疾病的新型寡核苷酸疗法
- 批准号:
16K20646 - 财政年份:2016
- 资助金额:
$ 42.49万 - 项目类别:
Grant-in-Aid for Young Scientists (B)